This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Medisapiens Oy. Active years: 2015-2018.
Company Filing History:
Years Active: 2015-2018
Title: Kalle Ojala: Innovator in Medical Analysis
Introduction
Kalle Ojala is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of medical analysis through his innovative methods and technologies. With a total of 2 patents, Ojala is recognized for his work in characterizing biological and medical samples.
Latest Patents
Ojala's latest patents focus on a computer executable method for analyzing biological or medical samples. This method utilizes a reference database to characterize query sample tissues based on gene expression data. The process involves calculating an expression match score (EM-score) to determine the likelihood of gene expression levels in various tissue categories. Additionally, it includes calculating a tissue specificity score (TS-score) to express how uniquely a gene identifies the query sample. The overall similarity of the sample tissue is then assessed in relation to the reference database, with the results stored or outputted for further analysis.
Career Highlights
Kalle Ojala is currently associated with Medisapiens Oy, a company that specializes in advanced medical analysis solutions. His work has been instrumental in developing innovative tools that enhance diagnostic capabilities in the medical field.
Collaborations
Ojala collaborates with notable professionals in his field, including Sami Kilpinen and Timo Ahopelto. These partnerships contribute to the advancement of research and development in medical technologies.
Conclusion
Kalle Ojala's contributions to medical analysis through his patented methods highlight his role as an innovator in the field. His work continues to influence diagnostic practices and improve healthcare outcomes.